Pharma Connect 2025 explores HVAC innovation and compliance in pharma manufacturing
ISHRAE Mumbai Chapter’s national conclave brought together pharma, HVAC, and regulatory professionals to discuss air conditioning,…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
Hikal inaugurates HPAPI Laboratory at Pune Innovation Centre to expand CDMO capabilities
Hikal has inaugurated a new High Potency Active Pharmaceutical Ingredient (HPAPI) Laboratory at its Integrated Innovation Centre…
Surge in out-licensing deals drive China’s international pharma collaborations: GlobalData
China’s out-licensing boom is driving record collaborations with US and EU pharma, expanding innovation beyond oncology into…
Roche, Lilly’s blood test for Alzheimer’s diagnosis gets US approval
FDA clears Roche and Lilly’s Elecsys blood test to aid early Alzheimer’s assessment, offering a less invasive alternative to…
WHO warns of contaminated India cough syrups
WHO alerts on toxic cough syrups in India, urges global monitoring
Implementation date for U.S. tariff on Singapore pharma exports postponed, local media reports
Delay in U.S. tariff gives Singapore pharma firms time to seek exemptions and assess impact on exports
Cadila Pharmaceuticals launches Dlorfast-M tablets for management of allergic rhinitis and urticaria
The new fixed-dose combination of Desloratadine and Montelukast aims to support patients with respiratory and skin-related…
Jubilant HollisterStier launches third Sterile Fill & Finish line at Spokane facility
New line increases sterile injectable capacity by 50% and advances Jubilant Pharmova’s multi-phase expansion strategy in the US
Lupin to present Phase 1a clinical trial data of STING agonist LNP3693 at ESMO Congress 2025
Lupin to share findings on LNP3693’s safety, pharmacokinetics, and anti-tumour activity in advanced solid tumours and lymphoma at…
Bristol Myers Squibb launches Kopozgo (Mavacamten) in India for obstructive hypertrophic…
Kopozgo is the first and only oral cardiac myosin inhibitor approved in India for treating adults with symptomatic obstructive…
Unani Medicine: At crossroads of tradition and modernity
Manufacturers,academic institutions and research councils are working together to elevate Unani medicine through clinical…
New GMP standards in India expose fault line between regulators and MSMEs: GlobalData
GlobalData report highlights MSME concerns over India’s revised GMP and bio-equivalence mandates, warning that rapid enforcement…
GSK’s Nashik plant receives global BSI AMR Kitemark certification
Certification recognises GSK’s adherence to international standards for antibiotic manufacturing and commitment to antimicrobial…
Torrent Group’s UNM Foundation opens ‘Sankalan’ neuro rehab centre in Ahmedabad
The 30,000-square-foot Sankalan facility aims to provide integrated neuro rehabilitation care to underprivileged patients,…
The high cost of compromise: Why patient safety must come first
Dr Ranjit Barshikar, CEO – QbD International, United Nations Advisor cautions that India’s reputation as the ‘Pharmacy of the…
Natco to launch generic of Risdiplam for SMA patients
The company said it will launch the product immediately, with MRP of ₹15,900
Jubilant HollisterStier launches high-speed isolator based line at Spokane facility in US
This $132 million investment brings an additional 50 per cent capacity at its Spokane manufacturing facility
NSF, IDMA sign MoU to improve cGMP framework for India’s nutra industry
As per the MoU, NSF and IDMA will develop a tailored cGMP framework for Indian FBOs based on best global practices
Deal value increased by 320 per cent in September 2025, compared to September 2024
Three major deals contributed 79.7 per cent of the total deal value during September 2025
Lupin launches strategic partnership program to expand reach of its long-acting injectable platform
Following U.S. FDA approval for the first product using PrecisionSphere, Lupin’s new initiative aims to collaborate with global…